RxDoctor Payments Data

Zachary Smith, DO

Gastroenterology · Milwaukee, WINPI 1003048976

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $3,475 of the $4,403 with a category attached, or 78.9%. US Endoscopy accounts for 78.9% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $3,291 and has fallen 95.9% since, to $134 in 2025.

$4,403in general payments, 2019–2025

Across 27 payments — averaging $163.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • US Endoscopy$3K
  • Conmed Corporation$273
  • Boston Scientific$232
  • AbbVie$212
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$140
  • Takeda Pharmaceuticals U.S.A., Inc.$57
  • plus $15 from 1 others

What the payments were for

  • Consulting fees$3,47579%
  • Food & beverage$92821%

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,403 in reported general payments places this provider in the 85th percentile of 285 gastroenterology providers in Wisconsin.

See all gastroenterology providers in Wisconsin

Medicare billing

Part B allowed, 2024
$21,724
Medicare patients
71
Services billed
115

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl12$220

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Milwaukee

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →